New antibody drug targets Hard-to-Treat cancers in first human trial
Disease control
Recruiting now
This early-stage study tests a new drug called CBA-1205 in people with advanced solid tumors (like liver cancer or melanoma) that have not responded to other treatments. The main goal is to check the drug's safety and find the best dose. About 66 participants will receive the dru…
Phase: PHASE1 • Sponsor: Chiome Bioscience Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC